Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable non-squamous non-small cell lung cancers

INTRODUCTION: Bevacizumab improves survival in patients with advanced non-small cell lung cancer (NSCLC). This phase II clinical trial assessed the effects of the addition of bevacizumab to neoadjuvant chemotherapy in resectable non-squamous NSCLC. METHODS: Patients with resectable stage IB-IIIA non...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chaft, Jamie E., Rusch, Valerie, Ginsberg, Michelle S., Paik, Paul K., Finley, David J., Kris, Mark G., Price, Katharine A.R., Azzoli, Christopher. G., Fury, Matthew G., Riely, Gregory J., Krug, Lee M., Downey, Robert J., Bains, Manjit S., Sima, Camelia S., Rizk, Nabil, Travis, William D., Rizvi, Naiyer A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4191830/
https://ncbi.nlm.nih.gov/pubmed/23857398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31829923ec
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados